NCT04463914

Evaluation of a Mobile Therapy for Elevated Depressive Symptoms

Development and Testing of a Behavioral Activation Mobile Therapy for Elevated Depressive Symptoms

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 649 (actual)
• Sponsor: Medical University of South Carolina · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this research study is to evaluate a mobile application (app) for depression treatment. Participants will be randomly assigned to either receive the mobile app, "Moodivate", or not. If provided with Moodivate, participants will be asked to use the app regularly, at least once per day, throughout the study duration. Participants will be asked to complete electronic questionnaire measures throughout the study period. Participation in this study will take about 12 weeks.

Conditions

• Depressive Symptoms
• Depression

Interventions

Type	Name	Description
BEHAVIORAL	Behavioral Activation Therapy app	Moodivate focuses on tracking daily activities, recording daily mood, and identifying new activities to complete that may help improve mood. Participants will be asked to complete questionnaire measures weekly for 8 weeks, with a final follow-up questionnaire at 12 weeks following study enrollment.
BEHAVIORAL	Behavioral Activation Therapy app + EHR	Moodivate focuses on tracking daily activities, recording daily mood, and identifying new activities to complete that may help improve mood. The participant's primary care provider at MUSC will be provided access to a Moodivate provider portal that was developed by study team. Participants will be asked to complete questionnaire measures weekly for 8 weeks, with a final follow-up questionnaire at 12 weeks following study enrollment.
BEHAVIORAL	Treatment as Usual	Participants will be provided educational material about mood management available via the EHR with the suggestion to discuss questions with their PCP. Participants will be asked to complete questionnaire measures weekly for 8 weeks, with a final follow-up questionnaire at 12 weeks following study enrollment.

Timeline

• Start date: 2021-10-12
• Primary completion: 2024-01-04
• Completion: 2024-03-29
• First posted: 2020-07-09
• Last updated: 2024-11-19
• Results posted: 2024-11-19

Locations

1 site across 1 country: United States